Effects of Online Cognitive Control Training on Rumination and Depressive Symptoms
NCT ID: NCT03011216
Last Updated: 2022-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2018-07-01
2021-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Cognitive Control Training for Remitted Depressed Patients
NCT03278756
Effectiveness of an Ecological Momentary Emotion Regulation Intervention
NCT06311136
Cognitive Control Training for Remitted Depressed Patients
NCT02407652
Psychophysiological Correlates of Mindfulness Based Cognitive Therapy (MBCT) in Recurrent Depression
NCT00974077
Efficacy of Gamified Cognitive Control Training Using de:)Press on Depression Severity add-on to Treatment as Usual
NCT05385614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the present study is to examine whether training to update emotional material in working memory will have an effect on the frequency of using rumination as well as on the impact of rumination on mood in the daily lives of clinically depressed participants. Participants will be randomly assigned to 10 sessions of either online cognitive control training or an online placebo condition. The ability to update emotional material in working memory will be assessed pre and post training by two computer tasks (close and far transfer tasks). The effects of the training on daily rumination and the dynamics between daily mood and rumination will be assessed pre- and post-training, as well as at 3-months follow-up using ambulatory assessment (via smartphone app). It is expected that individuals in the training as compared to the placebo group will show a greater reduction in rumination frequency as well as a reduction in the negative impact of rumination on mood.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adaptive emotional cognitive control training
Adaptive emotional n-back task: On each trial of this task, participants are presented with an emotional facial expression. Participants have to indicate whether the emotion presented in the current trial is the same as n trials back. In order to train participants at their individual ability level, the n-level varies by trial block based on participants' performance on the previous block.
The adaptive emotional n-back task is assumed to train the ability to continuously update emotional material in working memory.
Adaptive emotional cognitive control training
Is supposed to train ability to continuously update emotional material in working memory.
Placebo training
Adaptive non-emotional feature match task: On each trial of this task, participants are presented with two panels containing 8-12 shapes each. Participants are asked to compare the two panels and decide whether or not they are identical. The panels contain a minimum of 8 shapes and a maximum of 12 shapes, depending on participants' performance on the previous block.
The adaptive non-emotional feature match task is assumed to train the speed of responding (involving processes like visual search and concentration). It does not trait working memory updating.
Adaptive non-emotional feature match task
Does not train updating of working memory content; may train reaction time speed, visual search, or concentration abilities.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adaptive emotional cognitive control training
Is supposed to train ability to continuously update emotional material in working memory.
Adaptive non-emotional feature match task
Does not train updating of working memory content; may train reaction time speed, visual search, or concentration abilities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-65 years of age
* German native language (due to verbal task requirements)
Exclusion Criteria
* substance use disorder within past 12 months
* current obsessive-compulsive disorder (OCD) or borderline personality disorder (BPS)
* reporting severe underweight (BMI\<18), any neurological disease, severe head injury (e.g. severe concussion), or any brain damage (e.g. due to stroke)
* concurrent psychotherapy during the duration of the study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Stuttgart
OTHER
University Ghent
OTHER
Freie Universität Berlin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ulrike Zetsche
Dr. rer. nat.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrike Zetsche, Dr.
Role: PRINCIPAL_INVESTIGATOR
Freie Universität Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Freie Universität Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZE 1029/3-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.